Banco Santander’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$25M Buy
105,152
+5,482
+6% +$1.14M 0.16% 100
2026
Q1
$21.1M Hold
99,670
0.17% 101
2025
Q4
$20.5M Sell
99,670
-17,684
-15% -$3.33M 0.15% 106
2025
Q3
$18.4M Buy
117,354
+13,228
+13% +$2.04M 0.16% 103
2025
Q2
$17.5M Buy
+104,126
New +$15.5M 0.17% 101
2024
Q4
Sell
-1,957
Closed -$216K 457
2024
Q3
$216K Sell
1,957
-44,219
-96% -$4.62M ﹤0.01% 418
2024
Q2
$4.54M Buy
+46,176
New +$4.71M 0.06% 182
2023
Q3
Sell
-3,843
Closed -$363K 429
2023
Q2
$363K Buy
+3,843
New +$325K ﹤0.01% 370
2021
Q1
Sell
-4,352
Closed -$233K 390
2020
Q4
$233K Buy
+4,352
New +$226K ﹤0.01% 354
2018
Q2
Sell
-4,293
Closed -$269K 384
2018
Q1
$269K Buy
+4,293
New +$295K ﹤0.01% 356

Other funds holding CAH

Banco Santander's CAH Position: Q2 2026 in Review

Banco Santander increased its Cardinal Health (CAH) stake by 5.5% in Q2 2026, buying an estimated $1.14M and bringing the position to 105,152 shares worth $25M. The position accounts for 0.16% of the portfolio, ranked #100.

Banco Santander first reported a position in CAH in Q1 2018 and has held it in 10 quarters since. 1,496 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Banco Santander held 105,152 shares of Cardinal Health worth $25M as of Q2 2026.
  • Banco Santander bought 5,482 Cardinal Health shares in Q2 2026, an estimated $1.14M.
  • Cardinal Health made up 0.16% of Banco Santander's portfolio in Q2 2026, its #100 holding.
  • Banco Santander first reported a position in Cardinal Health in Q1 2018 and has held it in 10 quarters since.
  • 1,496 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Banco Santander's 13F filing for Q2 2026, filed 29 Jul 2026.